Cargando…
rna interference and micro rna –oriented therapy in cancer: rationales, promises, and challenges
The discovery that rna interference (rnai) and its functional derivatives, small interfering rnas (sirnas) and micro-rnas (mirnas) could mediate potent and specific gene silencing has raised high hopes for cancer therapeutics. The prevalence of these small (18–25 nucleotide) non-coding rnas in human...
Autores principales: | Duchaine, T.F., Slack, F.J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722055/ https://www.ncbi.nlm.nih.gov/pubmed/19672426 |
Ejemplares similares
-
Novel developments in angiogenesis cancer therapy
por: Hirte, H.W.
Publicado: (2009) -
Development of cell-cycle inhibitors for cancer therapy
por: Dickson, M.A., et al.
Publicado: (2009) -
Small-molecule Bcl-2 antagonists as targeted therapy in oncology
por: Warr, M.R., et al.
Publicado: (2008) -
Targeting mtor-dependent tumours with specific inhibitors: a model for personalized medicine based on molecular diagnoses
por: Furic, L., et al.
Publicado: (2009) -
Histone deacetylase inhibitors as novel anticancer therapeutics
por: Walkinshaw, D.R., et al.
Publicado: (2008)